Table 2.
predictive factors of the progression/ recurrence of thyroid carcinoma
| Pregnant women | Control Group | Univariate Analysis | Multivariate Analysis | |||||
|---|---|---|---|---|---|---|---|---|
| (N = 42) | % | (N=75) | % | uRR | 95% CI | aRR | 95% CI | |
| Persistence of cancer | 12 | 28 | 23 | 30 | 0.62 | 0.44-0.84 | 0.52 | 0.32-0.68 |
| Stage at diagnosis | 0.58 | 0.38-0.78 | 0.36 | 0.24-0.62 | ||||
| T1 | 22 | 53 | 38 | 50 | ||||
| T2 | 10 | 24 | 22 | 29 | ||||
| T3 | 6 | 13 | 10 | 14 | ||||
| T4 | 4 | 10 | 5 | 7 | ||||
| N0 | 24 | 57 | 30 | 40 | ||||
| N1 | 10 | 24 | 35 | 46 | ||||
| Radio-iodine ablation | 9 | 16 | 49 | 65 | 0.74 | 0.52-0.92 | 0.58 | 0.44-0.74 |
| Months of follow-up | 14.45 ± 2.4 | - | 18.24 ± 3.7 | - | - | - | - | - |
| Thyroglobulin preconception (ng/ml) | 1.75 | - | 1.88 | - | - | - | - | - |
| Distant metastases | 3 | 25 | 18 | 24 | 0.49 | 0.34-0.64 | 0.32 | 0.22-0.52 |
| Pregnancy | 42 | 100 | 0 | 0 | 1.36 | 1.14-1.58 | 1.04 | 0.91-1.32 |